670nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models
- PMID: 23951291
- PMCID: PMC3738508
- DOI: 10.1371/journal.pone.0072135
670nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models
Abstract
Introduction: To investigate the validity of using 670nm red light as a preventative treatment for Retinopathy of Prematurity in two animal models of oxygen-induced retinopathy (OIR).
Materials and methods: During and post exposure to hyperoxia, C57BL/6J mice or Sprague-Dawley rats were exposed to 670 nm light for 3 minutes a day (9J/cm²). Whole mounted retinas were investigated for evidence of vascular abnormalities, while sections of neural retina were used to quantify levels of cell death using the TUNEL technique. Organs were removed, weighed and independent histopathology examination performed.
Results: 670 nm light reduced neovascularisation, vaso-obliteration and abnormal peripheral branching patterns of retinal vessels in OIR. The neural retina was also protected against OIR by 670 nm light exposure. OIR-exposed animals had severe lung pathology, including haemorrhage and oedema, that was significantly reduced in 670 nm+OIR light-exposed animals. There were no significance differences in the organ weights of animals in the 670 nm light-exposed animals, and no adverse effects of exposure to 670 nm light were detected.
Discussion: Low levels of exposure to 670 nm light protects against OIR and lung damage associated with exposure to high levels of oxygen, and may prove to be a non-invasive and inexpensive preventative treatment for ROP and chronic lung disease associated with prematurity.
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3738508/bin/pone.0072135.g008.gif)
Similar articles
-
Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.Eye (Lond). 2019 Mar;33(3):363-373. doi: 10.1038/s41433-018-0205-1. Epub 2018 Sep 12. Eye (Lond). 2019. PMID: 30209267 Free PMC article.
-
Pathogenesis of retinopathy of prematurity and possible preventive strategies.Early Hum Dev. 2008 Feb;84(2):83-8. doi: 10.1016/j.earlhumdev.2007.11.008. Epub 2008 Jan 30. Early Hum Dev. 2008. PMID: 18234458 Review.
-
Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.Exp Eye Res. 2004 Nov;79(5):623-30. doi: 10.1016/j.exer.2004.07.006. Exp Eye Res. 2004. PMID: 15500821
-
Retinal vascular development and oxygen-induced retinopathy: a role for adenosine.Prog Retin Eye Res. 2003 Jan;22(1):95-111. doi: 10.1016/s1350-9462(02)00058-7. Prog Retin Eye Res. 2003. PMID: 12597925 Review.
-
Dexamethasone reduces oxygen induced retinopathy in a mouse model.Pediatr Res. 1999 Jul;46(1):94-100. doi: 10.1203/00006450-199907000-00016. Pediatr Res. 1999. PMID: 10400141
Cited by
-
Photobiomodulation Using Light-Emitting Diode (LED) for Treatment of Retinal Diseases.Clin Ophthalmol. 2024 Jan 22;18:215-225. doi: 10.2147/OPTH.S441962. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38283180 Free PMC article. Review.
-
Multi-Wavelength Photobiomodulation Ameliorates Sodium Iodate-Induced Age-Related Macular Degeneration in Rats.Int J Mol Sci. 2023 Dec 12;24(24):17394. doi: 10.3390/ijms242417394. Int J Mol Sci. 2023. PMID: 38139223 Free PMC article.
-
Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review.Int J Med Sci. 2023 Sep 4;20(10):1363-1376. doi: 10.7150/ijms.85746. eCollection 2023. Int J Med Sci. 2023. PMID: 37786442 Free PMC article. Review.
-
Evaluation of Photobiomodulation and Boldine as Alternative Treatment Options in Two Diabetic Retinopathy Models.Int J Mol Sci. 2023 Apr 27;24(9):7918. doi: 10.3390/ijms24097918. Int J Mol Sci. 2023. PMID: 37175628 Free PMC article.
-
Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases.Biomolecules. 2022 Dec 3;12(12):1811. doi: 10.3390/biom12121811. Biomolecules. 2022. PMID: 36551239 Free PMC article. Review.
References
-
- Hakeem AH, Mohamed GB, Othman MF (2012) Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol 19: 289-294. doi:10.4103/0974-9233.97927. PubMed: 22837621. - DOI - PMC - PubMed
-
- Giusti B, Vestrini A, Poggi C, Magi A, Pasquini E et al. (2012) Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants. Free Radic Res 46: 1130-1139. doi:10.3109/10715762.2012.692787. PubMed: 22574884. - DOI - PubMed
-
- Chen J, Stahl A, Hellstrom A, Smith LE (2011) Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 23: 173-178. doi:10.1097/MOP.0b013e3283423f35. PubMed: 21150442. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources